← 返回

泛肿瘤 T 淋巴细胞检测使用深度神经网络:免疫组织化学中迁移学习的建议

英文原题:Pan-tumor T-lymphocyte detection using deep neural networks: Recommendations for transfer learning in immunohistochemistry.

查看英文原题

Pan-tumor T-lymphocyte detection using deep neural networks: Recommendations for transfer learning in immunohistochemistry.

PubMed 2023/02/27(内容时间) J Pathol Inform

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫肿瘤治疗的成功为越来越多的患者带来了长期癌症缓解的希望。对检查点抑制剂药物的反应已显示与肿瘤及肿瘤微环境中免疫细胞的存在相关。

因此,深入理解免疫细胞的空间定位对于理解肿瘤的免疫景观和预测药物反应至关重要。计算机辅助系统非常适合在其空间背景下高效量化免疫细胞。传统的图像分析方法通常基于颜色特征,因此需要大量的人工交互。基于深度学习的更稳健的图像分析方法有望减少这种对人类交互的依赖,并提高免疫细胞评分的可重复性。

然而,这些方法需要足够的训练数据,且先前的工作报道,当这些算法在不同病理实验室的分布外数据或不同器官的样本上进行测试时,其稳健性较低。在这项工作中,我们使用了一种新的图像分析流程,明确评估了标记物标记的淋巴细胞量化算法在转移到新肿瘤适应症之前和之后,其稳健性随训练样本数量的变化。在这些实验中,我们调整了 RetinaNet 架构用于 T 淋巴细胞检测任务,并采用迁移学习来弥合肿瘤适应症之间的域差距,并降低未见过域的标注成本。在我们的测试集上,我们几乎对所有肿瘤适应症都达到了人类水平的性能,域内平均精度为 0.74,跨域为 0.72-0.74。根据我们的结果,我们得出了关于注释范围、训练样本选择和标签提取的模型开发建议,以开发稳健的免疫细胞评分算法。通过将标记标记的淋巴细胞量化任务扩展为多类检测任务,满足了后续分析的前提条件,例如区分肿瘤基质中的淋巴细胞与TIL(肿瘤浸润淋巴细胞)。

展开英文摘要原文

The success of immuno-oncology treatments promises long-term cancer remission for an increasing number of patients. The response to checkpoint inhibitor drugs has shown a correlation with the presence of immune cells in the tumor and tumor microenvironment. An in-depth understanding of the spatial localization of immune cells is therefore critical for understanding the tumor's immune landscape and predicting drug response.

Computer-aided systems are well suited for efficiently quantifying immune cells in their spatial context. Conventional image analysis approaches are often based on color features and therefore require a high level of manual interaction. More robust image analysis methods based on deep learning are expected to decrease this reliance on human interaction and improve the reproducibility of immune cell scoring.

However, these methods require sufficient training data and previous work has reported low robustness of these algorithms when they are tested on out-of-distribution data from different pathology labs or samples from different organs. In this work, we used a new image analysis pipeline to explicitly evaluate the robustness of marker-labeled lymphocyte quantification algorithms depending on the number of training samples before and after being transferred to a new tumor indication. For these experiments, we adapted the RetinaNet architecture for the task of T-lymphocyte detection and employed transfer learning to bridge the domain gap between tumor indications and reduce the annotation costs for unseen domains.

On our test set, we achieved human-level performance for almost all tumor indications with an average precision of 0. 74 in-domain and 0. 72-0. 74 cross-domain. From our results, we derive recommendations for model development regarding annotation extent, training sample selection, and label extraction for the development of robust algorithms for immune cell scoring.

By extending the task of marker-labeled lymphocyte quantification to a multi-class detection task, the pre-requisite for subsequent analyses, e. g. , distinguishing lymphocytes in the tumor stroma from tumor-infiltrating lymphocytes, is met.

论文信息

作者
Wilm F、Ihling C、Méhes G、Terracciano L、Puget C、Klopfleisch R、Schüffler P、Aubreville M
第一作者单位
Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.Germany
通讯作者单位
Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.Germany
期刊
Journal of pathology informatics2023
原文标识
PubMed 36994311 · DOI 10.1016/j.jpi.2023.100301